Market Tracker

12/02 5:16pm ET

Pluristem Therapeutics Inc (NASDAQ:PSTI)

1.47
Delayed Data
As of Dec 02
 +0.02 / +1.38%
Today’s Change
0.71
Today|||52-Week Range
1.85
+30.09%
Year-to-Date
No recent news for Pluristem Therapeutics Inc.

Today’s Trading

Previous close1.45
Today’s open1.45
Day’s range1.43 - 1.47
Volume76,827
Average volume (3 months)136,422
Market cap$117.5M
Dividend yield--
Data as of 3:59pm ET, 12/02/2016

Growth & Valuation

Earnings growth (last year)+17.14%
Earnings growth (this year)--
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+651.19%
P/E ratioNM
Price/Sales37.16
Price/Book3.05

Competitors

 Today’s
change
Today’s
% change
AUPHAurinia Pharmaceutic...-0.07-2.36%
BPTHBio Path Holdings In...+0.02+1.63%
ADVMAdverum Biotechnolog...+0.05+1.79%
AXSMAxsome Therapeutics ...-0.10-1.60%
Data as of 3:59pm ET, 12/02/2016

Financials

Next reporting dateFebruary 3, 2017
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$2.8M
Annual profit (last year)-$23.2M
Net profit margin-816.51%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Zami Aberman
President, COO, CFO, Secretary &
Director
Yaky Yanay
Corporate headquarters
Haifa, Haifa

Forecasts